CHANGES IN DIGNITANA'S FINANCING
Lund 27 October 2017 - Dignitana AB, a world leader in medical scalp cooling technology and manufacturer of The DigniCap® Scalp Cooling System, announced today that the company's largest customer, Memorial Sloan Kettering (MSK), has requested to renegotiate its long-term agreement to be replaced by a short-term agreement with an ongoing relationship. MSK is now reviewing its treatment processes. This implies changes in Dignitana’s short-term financing structure, which means that the company’s working capital will be consumed in mid-November.
The company is working to find a financial solution both short and long term.
Caren Browning Semmy Rülf
King + Company Chairman of the board, Dignitana AB
00 1 212 561-7464 +46 (0)709-312730
About Dignitana AB (publ)
Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For more information visit www.dignitana.se
About The DigniCap® Scalp Cooling System
DigniCap® is a patented scalp cooling system that offers cancer patients the ability to keep their hair during chemotherapy. DigniCap® provides continuous cooling with high efficacy, safety and acceptable patient comfort. www.dignicap.com
This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 3.15 pm (CEST), 27 October 2017.